Rocket Lab (NASDAQ:RKLB) Stock Price Up 1.1% – Time to Buy?

Rocket Lab Corporation (NASDAQ:RKLB)’s share price shot up 1.1% during mid-day trading on Thursday. The company traded as high as $72.64 and last traded at $70.46. 23,137,714 shares changed hands during mid-day trading, an increase of 0% from the average session volume of 23,065,313 shares. The stock had previously closed at $69.68.

More Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Record Synspective contract: Rocket Lab signed its largest-ever commercial Electron agreement: 20 dedicated launches for Synspective’s StriX Earth-imaging satellites, scheduled annually from 2028 through 2031. The deal raises Synspective’s total bookings to 47 missions and pushes Rocket Lab’s overall launch backlog above 100 missions. Financial terms were not disclosed. Rocket Lab Secures Largest-Ever Electron Commercial Deal
• Positive Sentiment: Citi initiates coverage with Buy: Citi analyst John Godyn called Rocket Lab a “core holding for space bulls” and assigned a $105 price target. The recommendation highlights Electron’s established launch record, Rocket Lab’s broader space-systems business and potential long-term growth, giving the stock fresh Wall Street support. Citi Just Upgraded Rocket Lab Stock
• Positive Sentiment: Institutional and investor support: Cathie Wood’s ARK Invest reportedly added about $26 million of RKLB shares, following roughly $71 million of purchases in September. The buying may reinforce the recovery narrative after the stock’s earlier decline. Cathie Wood’s ARK Invest Boosted Its Rocket Lab Stake
• Neutral Sentiment: Growth milestones remain crucial: Investors are watching whether Rocket Lab can execute the expanding Electron backlog, advance its Neutron medium-lift rocket and convert its broader space portfolio into sustainable revenue and profitability. Analysts’ published targets generally imply additional upside, but the company remains loss-making.
• Negative Sentiment: Valuation and dilution concerns: Rocket Lab’s pending Iridium acquisition required substantial equity financing, increasing dilution concerns and adding integration and balance-sheet risks. Separately, reported insider activity shows extensive selling and no open-market purchases over the past six months, which may temper bullish sentiment.
• Negative Sentiment: Competitive and execution risks: SpaceX’s Starship reaching orbit highlights the potential for lower-cost, higher-capacity competition over time, even though Starship’s current limitations could benefit dedicated small-launch providers such as Rocket Lab.

Wall Street Analyst Weigh In

A number of brokerages recently commented on RKLB. Berenberg Bank assumed coverage on Rocket Lab in a research note on Wednesday, September 2nd. They set a “buy” rating and a $83.00 price objective for the company. Craig Hallum upped their price target on Rocket Lab from $98.00 to $120.00 and gave the stock a “buy” rating in a research report on Monday, June 29th. Morgan Stanley reiterated an “overweight” rating on shares of Rocket Lab in a report on Wednesday, July 8th. Needham & Company LLC reiterated a “buy” rating on shares of Rocket Lab in a research note on Tuesday, August 11th. Finally, Stifel Nicolaus set a $132.00 target price on Rocket Lab in a research note on Thursday, June 4th. Four investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $107.20.

Rocket Lab Trading Up 1.1%

The firm has a market capitalization of $42.16 billion, a price-to-earnings ratio of -260.95 and a beta of 2.60. The firm’s 50-day moving average is $69.56 and its 200 day moving average is $84.40. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The company had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. On average, equities analysts predict that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Rocket Lab news, CFO Adam C. Spice sold 140,157 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $62.63, for a total value of $8,778,032.91. Following the completion of the transaction, the chief financial officer owned 1,155,967 shares in the company, valued at $72,398,213.21. This trade represents a 10.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Frank Klein sold 35,558 shares of the firm’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $66.61, for a total transaction of $2,368,518.38. Following the completion of the transaction, the insider owned 925,737 shares of the company’s stock, valued at $61,663,341.57. This trade represents a 3.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 3,536,371 shares of company stock worth $303,442,641 in the last quarter. Insiders own 8.40% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of RKLB. Marathon Mission Inc. bought a new position in Rocket Lab in the third quarter valued at $221,000. Cim Investment Management Inc. bought a new position in shares of Rocket Lab during the second quarter valued at about $1,399,000. QRG Capital Management Inc. boosted its holdings in Rocket Lab by 164.7% during the 2nd quarter. QRG Capital Management Inc. now owns 97,177 shares of the rocket manufacturer’s stock valued at $9,878,000 after acquiring an additional 60,461 shares during the period. Envestnet Portfolio Solutions Inc. increased its stake in Rocket Lab by 231.1% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 16,292 shares of the rocket manufacturer’s stock worth $1,656,000 after purchasing an additional 11,372 shares during the period. Finally, Andra AP fonden increased its stake in shares of Rocket Lab by 2,547.4% in the second quarter. Andra AP fonden now owns 416,676 shares of the rocket manufacturer’s stock worth $42,355,000 after buying an additional 400,937 shares during the period. 71.78% of the stock is currently owned by institutional investors.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.